Alvarez & Marsal Launches Life Sciences Business Unit
Alvarez & Marsal has launched a new Life Sciences Business Unit to address evolving industry challenges. The unit brings together deep expertise in pharmaceuticals, biotechnology, and medical devices.
Alvarez & Marsal (A&M), a global professional services firm, has announced the establishment of a dedicated Life Sciences Business Unit. This new division is designed to address complex industry challenges and provide comprehensive solutions.
The unit is led by a team of managing directors and senior directors with extensive experience across pharmaceuticals, biotechnology, medical devices, digital health, and pharma services. This leadership group collectively possesses over a century of combined experience in the sector.
The Life Sciences Business Unit will leverage A&M's operational heritage, alongside its expertise in corporate finance, strategic planning, and risk management, to assist clients in navigating the intricate landscape of the life sciences industry. The firm emphasizes an outcomes-driven approach to meet current and future client demands.
Alvarez & Marsal is a privately held global professional services firm specializing in advisory, business performance improvement, and turnaround management. Founded in 1983, the firm operates across six continents, assisting companies, investors, and government entities with complex challenges.